annb0t
Top 20
Neuren Pharmaceuticals (ASX:NEU) Full Year 2024 Results
Key Financial Results
Revenue: AU$216.8m (down 6.5% from FY 2023). Net income: AU$142.0m (down 9.6% from FY 2023). Profit margin: 66% (down from 68% in FY 2023). EPS: AU$1.11 (down from AU$1.24 in FY 2023).ASX:NEU Revenue and Expenses Breakdown March 4th 2025
All figures shown in the chart above are for the trailing 12 month (TTM) period
Neuren Pharmaceuticals Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates b...
>>> Read more: Neuren Pharmaceuticals Full Year 2024 Earnings: Beats Expectations
Key Financial Results
Revenue: AU$216.8m (down 6.5% from FY 2023). Net income: AU$142.0m (down 9.6% from FY 2023). Profit margin: 66% (down from 68% in FY 2023). EPS: AU$1.11 (down from AU$1.24 in FY 2023).ASX:NEU Revenue and Expenses Breakdown March 4th 2025
All figures shown in the chart above are for the trailing 12 month (TTM) period
Neuren Pharmaceuticals Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates b...
>>> Read more: Neuren Pharmaceuticals Full Year 2024 Earnings: Beats Expectations
